ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
ProShares K 1 Free Crude Oil Strategy ETF

ProShares K 1 Free Crude Oil Strategy ETF (OILK)

43.45
0.17
( 0.39% )
Updated: 13:47:54

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
43.45
Bid
-
Ask
-
Volume
5,270
42.98 Day's Range 43.45
40.21 52 Week Range 51.00
Market Cap
Previous Close
43.28
Open
43.22
Last Trade
10
@
43.45
Last Trade Time
13:45:31
Financial Volume
$ 228,336
VWAP
43.3275
Average Volume (3m)
54,178
Shares Outstanding
2,884,000
Dividend Yield
-
PE Ratio
6.22
Earnings Per Share (EPS)
6.98
Revenue
5.54M
Net Profit
20.13M

About ProShares K 1 Free Crude Oil Strategy ETF

The investment seeks to provide total return through actively managed exposure to the West Texas Intermediate crude oil futures markets. The funds strategy seeks to outperform certain index based strategies by actively managing the rolling of WTI crude oil futures contracts. The fund generally will ... The investment seeks to provide total return through actively managed exposure to the West Texas Intermediate crude oil futures markets. The funds strategy seeks to outperform certain index based strategies by actively managing the rolling of WTI crude oil futures contracts. The fund generally will not invest directly in WTI crude oil futures. The advisor expects to gain exposure to these investments by investing a portion of its assets in the ProShares Cayman Crude Oil Strategy Portfolio, a wholly-owned subsidiary of the fund organized under the laws of the Cayman Islands. It is non-diversified. Show more

Sector
Mgmt Invt Offices, Open-end
Industry
Mgmt Invt Offices, Open-end
Headquarters
Wilmington, Delaware, USA
Founded
-
ProShares K 1 Free Crude Oil Strategy ETF is listed in the Mgmt Invt Offices, Open-end sector of the American Stock Exchange with ticker OILK. The last closing price for ProShares K 1 Free Crude... was $43.28. Over the last year, ProShares K 1 Free Crude... shares have traded in a share price range of $ 40.21 to $ 51.00.

ProShares K 1 Free Crude... currently has 2,884,000 shares outstanding. The market capitalization of ProShares K 1 Free Crude... is $124.82 million. ProShares K 1 Free Crude... has a price to earnings ratio (PE ratio) of 6.22.

OILK Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.33.0842230130542.1543.579941.711695542.52287844SP
4-1.6-3.5516093229745.0546.68540.215624543.63022515SP
12-5.19-10.670230263248.6449.6440.215417845.20093141SP
26-3.7-7.8472958642647.1550.3940.214961346.07293595SP
52-6.6-13.186813186850.055140.216417245.2362333SP
156-17.92-29.199934821661.3764.7537.57445531847.19245788SP
26022.16104.08642555221.2964.756.765880537.84675458SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CEROCERo Therapeutics Holdings Inc
$ 0.1885
(116.67%)
94.33M
BNZIBanzai International Inc
$ 5.4899
(90.62%)
56.33M
XPONExpion360 Inc
$ 0.0972
(67.01%)
1.36B
IMRXImmuneering Corporation
$ 3.21
(32.64%)
16.56M
LFLYLeafly Holdings Inc
$ 2.3599
(31.84%)
27.72M
GSIWGarden Stage Ltd
$ 2.16
(-72.41%)
13.62M
CRBPCorbus Pharmaceuticals Holdings Inc
$ 21.43
(-58.55%)
9.59M
LGCBLinkage Global Inc
$ 0.4099
(-58.55%)
1.9M
SKYESkye Bioscience Inc
$ 3.21
(-41.53%)
3.38M
KOPNKopin Corporation
$ 0.6311
(-34.54%)
9.95M
XPONExpion360 Inc
$ 0.0972
(67.01%)
1.36B
NVDANVIDIA Corporation
$ 116.265
(-1.36%)
173.94M
VERBVerb Technology Company Inc
$ 0.069
(24.10%)
147.93M
SQQQProShares UltraPro Short QQQ
$ 7.85
(1.16%)
106.71M
CEROCERo Therapeutics Holdings Inc
$ 0.1885
(116.67%)
94.33M

Discussion

View Full Feed
Smartypants2 Smartypants2 2 minutes ago
As you yourself noted, the judges' decisions in those two prior SDNY cases failed to consider that the convertible notes were, in fact, a form of security -- as had been determined in cases in other jurisdictions. Therefore, XERI persuasively argued that the presiding judge in XERI/XTI case incorrec
XERI
herbied47 herbied47 2 minutes ago
Swing idea. AZTR small float, recently received study may proceed letter from the FDA for INDA to treat skin rash from EGFR inhibitors, , recent offering at 1.50, recently announced three newly patents in US, China and Canada to treat inflammatory skin diseases, recent 1/30 reverse split, Maxim Grou
AZTR
capgain capgain 2 minutes ago
That would work too.
joe botts joe botts 2 minutes ago
Waiting and waiting and ....



Zzzzzz
TONR
koolmc koolmc 2 minutes ago
yep daily volume has been consistent this past week or so. Usually we would get volume like this and then next day zzz. Something is def up.
CNNA
3Angels120702 3Angels120702 2 minutes ago
Pretty nice volume especially for a Friday. Not huge dollar yet but getting there.
MWWC
lager lager 2 minutes ago
When soonfail posts it reminds me of the Charlie Brown teacher. "mwah mwah mwah mwah mwah".

MGON
herbied47 herbied47 2 minutes ago
Swing idea. AZTR small float, recently received study may proceed letter from the FDA for INDA to treat skin rash from EGFR inhibitors, , recent offering at 1.50, recently announced three newly patents in US, China and Canada to treat inflammatory skin diseases, recent 1/30 reverse split, Maxim Grou
AZTR
Milesblue42 Milesblue42 2 minutes ago
Next Week might Very Interesting Indeed....

Going to be interesting here!

The Longest Weekend ever 😁
RCAT
manibiotech manibiotech 2 minutes ago
So we have moved from Swift approval in Mar 24 , now to wait for anything meaningful for him to stop posting in Feb 25.
But what’s a year between friends .
NWBO
capgain capgain 3 minutes ago
A firing squad would be better.
ducci1 ducci1 3 minutes ago
Wagg 567P .33?
SPY
mick mick 4 minutes ago
https://www.stockscores.com/charts/charts/?ticker=GMGMF
GMG
Pyramid2 Pyramid2 4 minutes ago
$NBY - boom looking for pull back, 3% left

https://elite.finviz.com/published_idea.ashx?t=NBY&f=092024&i=NBYi1135932472i
NBY
capgain capgain 4 minutes ago
That's another reason they are letting them in, cheap labor for the corporations.
herbied47 herbied47 4 minutes ago
Swing idea. AZTR small float, recently received study may proceed letter from the FDA for INDA to treat skin rash from EGFR inhibitors, , recent offering at 1.50, recently announced three newly patents in US, China and Canada to treat inflammatory skin diseases, recent 1/30 reverse split, Maxim Grou
AZTR
manibiotech manibiotech 4 minutes ago
And which national payor or insurance is supposed to give revenue in next 12 months ??
NWBO
LCJR LCJR 4 minutes ago
That is incorrect information. They are not in bed with anyone. This is strictly a chain of salons providing top quality hair, nail and some tanning services with a Hollywood flair.

LCJR
AAGC
jammy32 jammy32 4 minutes ago
So idiots can say whatever they want

You realize it's against the TOS to post private messages without the other party's permission. I have sent your post to admin. Buh Bye clown.
ELTP
Triple nickle Triple nickle 5 minutes ago
Trying break thru forty
Guido2 Guido2 5 minutes ago
https://x.com/GuidoPerei/status/1837189616257917012
FNMA
learningcurve2020 learningcurve2020 5 minutes ago
Round and round we go. Two year old article. Yet we still see no evidence of additional survivors beyond the SOC established figures. Just where are those extra surviving patients speaking out on behalf of the treatment? It should amount to a lot of people by now.
NWBO
OTCNewbie OTCNewbie 5 minutes ago
barber you forgot to log into main account
DBMM
marcis marcis 5 minutes ago
How is revenue actually generated?

I doubt 10 bagger here LOL
SMCE

Your Recent History

Delayed Upgrade Clock